MMX® Mesalazine: A Review of its Use in the Management of Mild to Moderate Ulcerative Colitis

Author： Yang Lily P.H.   McCormack Paul L.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.71, Iss.2, 2011-01, pp. : 221-235

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Delayed-release MMX™ mesalazine: a guide to its use in ulcerative colitis

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 5, 2008-05 ,pp. : 6-8

Adis International

Access to resources Recommend Favorite

Balsalazide: A Review of its Therapeutic Use in Mild-to-Moderate Ulcerative Colitis

By Muijsers R.B.R.   Goa K.L.  

Drugs, Vol. 62, Iss. 11, 2002-01 ,pp. : 1689-1705

Adis International

Access to resources Recommend Favorite

Multi-Matrix System (MMX®) mesalamine for the treatment of mild-to-moderate ulcerative colitis

By Horst Sara N   Kane Sunanda  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 15, 2012-10 ,pp. : 2225-2232

Informa Healthcare

Access to resources Recommend Favorite

MMX makes the most of mesalazine in ulcerative colitis

By  

Inpharma, Vol. 1, Iss. 1565, 2006-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Oral Delayed-Release Mesalazine: A Review of its Use in Ulcerative Colitis and Crohn's Disease

By Prakash A.   Markham A.  

Drugs, Vol. 57, Iss. 3, 1999-03 ,pp. : 383-408

Adis International

Access to resources Recommend Favorite